Linked Life Data

20844879

Source:http://linkedlifedata.com/resource/pubmed/id/20844879

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-6-27
pubmed:abstractText
The need for new treatment options for acute myeloid leukemia (AML) is increasing. AS602868 is a novel investigational drug with reported activity on AML cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1432-0843
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
97-105
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868.
pubmed:affiliation
Université Lyon 1, ISPB, Lyon 69003, France. jordheim@yahoo.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't